Login / Signup

A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.

Michael J McCarthyYucui ChenAnna DemodenaSusan G LeckbandEileen FischerShahrokh GolshanTrisha SuppesJohn R Kelsoe
Published in: Journal of psychopharmacology (Oxford, England) (2021)
The data reveal possible group differences in the utility of PGX testing in veterans with TRD.ClinicalTrials.gov Identifier: NCT04469322.
Keyphrases
  • depressive symptoms
  • electronic health record
  • genome wide
  • single cell
  • big data
  • dna methylation